Juvantia Pharma Ltd clinical trials
Acquired by Santhera Pharmaceuticals, Oct 5, 2009 · source ↗
The registry lists 2 studies whose lead sponsor is Juvantia Pharma Ltd. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Jun 3, 2009.
Before and after it joined Santhera Pharmaceuticals
- First submitted before Juvantia Pharma Ltd became part of Santhera Pharmaceuticals
- 2
- First submitted after Juvantia Pharma Ltd became part of Santhera Pharmaceuticals
- 0
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
Registry sponsor names on this page
- Juvantia Pharma Ltd2 studies
Something wrong with this grouping? Tell us on the Santhera Pharmaceuticals page.
Studies
Recruiting first, then most recently updated. Showing 2 of 2. All Santhera Pharmaceuticals studies →
- Safety and Efficacy Study of Fipamezole in Treatment of Motor Dysfunctions in Parkinson's DiseaseCompletedNCT00559871Phase 2
Sponsor listed in the registry: Juvantia Pharma Ltd · First submitted before Juvantia Pharma Ltd became part of Santhera Pharmaceuticals
- Fipamezole in Neurogenic Orthostatic HypotensionStatus unknownNCT00758849Phase 2
Sponsor listed in the registry: Juvantia Pharma Ltd · First submitted before Juvantia Pharma Ltd became part of Santhera Pharmaceuticals